UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

Journal of clinical oncology, 2017-04, Vol.35 (11), p.1154-1161

2017

Volltextzugriff (PDF)

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets

Blood, 2014-05, Vol.123 (19), p.3016-3026

2014

Volltextzugriff (PDF)

Phase I study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies

Clinical cancer research, 2015-03, Vol.21 (6), p.1267-1272

2015

Volltextzugriff (PDF)

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

Haematologica (Roma), 2018-12, Vol.103 (12), p.2109-2115

2018

Volltextzugriff (PDF)

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

Bone marrow transplantation (Basingstoke), 2021-06, Vol.56 (6), p.1373-1380

2021

Volltextzugriff (PDF)

Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines

Transplantation and cellular therapy, 2023-02, Vol.29 (2), p.71-81

2023

Volltextzugriff (PDF)

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

Journal of clinical oncology, 2020-04, Vol.38 (12), p.1273-1283

2020

Volltextzugriff (PDF)

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

Blood cancer journal (New York), 2021-05, Vol.11 (5), p.96-96, Article 96

2021

Volltextzugriff (PDF)

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD

Haematologica (Roma), 2016-08, Vol.101 (8), p.e348-e351

2016

Volltextzugriff (PDF)

Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes

Cancer epidemiology, 2022-02, Vol.76, p.102090-102090, Article 102090

2022

Volltextzugriff (PDF)

Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients

Cancer chemotherapy and pharmacology, 2022-04, Vol.89 (4), p.543-549

2022

Volltextzugriff (PDF)

Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study

Transplantation and cellular therapy, 2021-01, Vol.27 (1), p.68.e1-68.e9

2021

Volltextzugriff (PDF)

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Blood advances, 2021-03, Vol.5 (5), p.1425-1436

2021

Volltextzugriff (PDF)

Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine

OncoTargets and therapy, 2010-09, Vol.3, p.157-165

2010

Volltextzugriff (PDF)

Factors predicting early mortality after new diagnosis of myelodysplastic syndrome: A population‐based study

European journal of haematology, 2019-07, Vol.103 (1), p.56-63

2019

Volltextzugriff (PDF)

Multiple transmissions of chromosomally integrated human herpesvirus‐6 in one family

Transplant infectious disease, 2018-02, Vol.20 (1), p.n/a

2018

Volltextzugriff (PDF)

Assessing acquired resistance to IDH1 inhibitor therapy by full-exon IDH1 sequencing and structural modeling

Cold Spring Harbor molecular case studies, 2021-04, Vol.7 (2), p.a006007

2021

Volltextzugriff (PDF)

Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies

Transplantation and cellular therapy, 2022-02, Vol.28 (2), p.88-95

2022

Volltextzugriff (PDF)

Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning

Translational research : the journal of laboratory and clinical medicine, 2016-09, Vol.175, p.103-115.e4

2016

Volltextzugriff (PDF)

Epidemiology of myelodysplastic syndromes: many questions remain

Leukemia & lymphoma, 2011-02, Vol.52 (2), p.163-164

Warlick, Erica D.

2011

Volltextzugriff (PDF)

Myelodysplastic syndromes: the role of the immune system in pathogenesis

Leukemia & lymphoma, 2011-11, Vol.52 (11), p.2045-2049

2011

Volltextzugriff (PDF)

Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy

Transplantation and cellular therapy, 2021-09, Vol.27 (9), p.773.e1-773.e8

2021

Volltextzugriff (PDF)

Absence of early HHV‐6 reactivation after cord blood allograft predicts powerful graft‐versus‐tumor effect

American journal of hematology, 2018-08, Vol.93 (8), p.1014-1019

2018

Volltextzugriff (PDF)

Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia: Similar Outcomes Regardless of Donor Type

Biology of blood and marrow transplantation, 2015-02, Vol.21 (2), p.357-363

2015

Volltextzugriff (PDF)

1 – 25 von 119

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Englisch
(119)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(52)
Science & Technology
(52)
Humans
(44)
Hematology
(38)
Middle Aged
(32)
Adult
(30)
Female
(29)
Male
(28)
Aged
(27)
Transplantation
(26)
Oncology
(23)
Immunology
(20)
Young Adult
(15)
Hematology, Oncology And Palliative Medicine
(14)
Transplantation, Homologous
(14)
Hematopoietic Stem Cell Transplantation
(13)
Myelodysplastic Syndrome
(12)
Myelodysplastic Syndromes - Therapy
(12)
Hematopoietic Stem Cell Transplantation - Methods
(11)
Retrospective Studies
(10)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets

Phase I study of a bispecific ligand-directed toxin targeting CD22 and CD19 (DT2219) for refractory B-cell malignancies

Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics

Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant

Hematopoietic Cell Transplantation in the Management of Myelodysplastic Syndrome: An Evidence-Based Review from the American Society for Transplantation and Cellular Therapy Committee on Practice Guidelines

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD

Personal history of autoimmune disease and other medical conditions and risk of myelodysplastic syndromes

Effects of cyclophosphamide related genetic variants on clinical outcomes of adult hematopoietic cell transplant patients

Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high‐risk myelodysplastic syndromes: Challenges and opportunities in implementation

Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study

First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings

Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine

Factors predicting early mortality after new diagnosis of myelodysplastic syndrome: A population‐based study

Multiple transmissions of chromosomally integrated human herpesvirus‐6 in one family

Assessing acquired resistance to IDH1 inhibitor therapy by full-exon IDH1 sequencing and structural modeling

Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies

Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning

Epidemiology of myelodysplastic syndromes: many questions remain

Myelodysplastic syndromes: the role of the immune system in pathogenesis

Higher Fludarabine and Cyclophosphamide Exposures Lead to Worse Outcomes in Reduced-Intensity Conditioning Hematopoietic Cell Transplantation for Adult Hematologic Malignancy

Absence of early HHV‐6 reactivation after cord blood allograft predicts powerful graft‐versus‐tumor effect

Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia: Similar Outcomes Regardless of Donor Type

Suchergebnisse filtern